CD163 and HIV infectious disease: We studied the effect of durable ART on plasma sCD163 of individuals with acute infection (ART treatment after less than one year of HIV infection) and chronic infection (ART treatment after more than one year of HIV infection) and found that plasma sCD163 levels decreased after 3 months to levels found in uninfected controls [58].